Iloprost down-regulates the expression of the growth regulatory gene Cyr61 in human vascular smooth muscle cells

European Journal of Pharmacology

Volumn 474, Issue 2-3, 2003, Pages 161-164

  Debey, Svenja ^a   Kirchrath, Lutz ^b   Schrör, Karsten ^a   Meyer Kirchrath, Jutta ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Thermo Fisher Scientific   (United States)

Author keywords

Atherosclerosis; CYR61; Iloprost; Prostacyclin; Smooth muscle

Indexed keywords

ILOPROST; MESSENGER RNA; PROSTACYCLIN DERIVATIVE;

ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CYR61 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTIMA; PRIORITY JOURNAL; RNA DEGRADATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0142102360     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02040-5     Document Type: Article

References (19)

1. Bretschneider E., Kaufmann R., Braun M., Nowak G., Glusa E., Schrör K. Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br. J. Pharmacol. 132:2001;1441-1446.
2. Brigstock D.R. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20:1999;189-206.
3. Grzeszkiewicz T.M., Kirschling D.J., Chen N.et al. CYR61 stimulates human skin fibroblast migration through integrin alpha v beta 5 and enhances mitogenesis through integrin alphavbeta 3, independent of its carboxyl-terminal domain. J. Biol. Chem. 276:2001;21943-21950.
4. Grzeszkiewicz T.M., Lindner V., Chen N., Lam S.C., Lau L.F. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology. 143:2002;1441-1450.
5. Hilfiker A., Hilfiker-Kleiner D., Fuchs M., Kaminski K., Lichtenberg A., Rothkotter H.J., Schieffer B., Drexler H. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation. 106:2002;254-260.
6. Kireeva M.L., MO F.E., Yang G.P.et al. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16:1996;1326-1334.
7. Kireeva M.L., Lam S.C., Lau L.F. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J. Biol. Chem. 273:1998;3090-3096.
8. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. J. Biol. Chem. 275:2000;14632-14641.
9. McNamara C.A., Sarembock I.J., Gimple L.W.et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:1993;94-98.
10. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1999;1193-1226.
11. Numaguchi Y., Naruse K., Harada M., Osanai H., Mokuno S., Murase K., Matsui H., Toki Y., Ito T., Okumura K., Hayakawa T. Prostacyclin synthase gene transfer accelerates reendothelialization and inhibits neointimal formation in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 19:1999;727-733.
12. O'Brien T.P., Yang G.P., Sanders L., Lau L.F. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10:1990;3569-3577.
13. Oemar B.S., Werner A., Garnier J.M.et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 95:1997;831-839.
14. Ross R. Atherosclerosis is an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
15. Schönbeck U., Sukhova G.K., Graber P.et al. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am. J. Pathol. 155:1999;1281-1291.
16. 2) and atherosclerosis. The Endothelium in Clinical Practice. 1997;1-44 Marcel Dekker, New York.
17. Stratton R., Shiwen X., Martini G., Holmes A., Leask A., Haberberger T., Martin G.R., Black C.M., Abraham D. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J. Clin. Invest. 108:2001;241-250.
18. Wu K.J., Yee A., Zhu N.L.et al. Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury. Int. J. Mol. Med. 6:2000;433-440.
19. Zucker T.P., Bönisch D., Hasse A.et al. Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells. Eur. J. Pharmacol. 345:1998;213-220.